Intraocular Pharmacokinetics and Safety of Subretinal Injection Compared with Intravitreal Application of Conbercept in Vitrectomized Rabbit Eyes
Purpose. To evaluate the ocular pharmacokinetic properties of subretinal conbercept injection in vitrectomized rabbit eyes and to compare them with those by intravitreal injection. Methods. The following groups of New Zealand white rabbits received conbercept injections (0.5 mg/0.05 ml): a subretina...
Saved in:
| Main Authors: | Teng-teng Yao, Xiao-liang Jin, Yuan Yang, Yi-xiao Wang, Ya-li Zhou, Fang-lin He, Zhao-yang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/2674780 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ocular pharmacokinetics of intravitreal conbercept in a rabbit model following retinal scatter laser photocoagulation
by: Lanlan Chen, et al.
Published: (2025-04-01) -
Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
by: Alireza Lashay, et al.
Published: (2020-01-01) -
Intravitreal Injection of Conbercept Combined with Minimally Invasive Photocoagulation and Phacoemulsification Intraocular Lens Implantation in the Treatment of Neovascular Glaucoma Complicated with Cataract
by: Xue Li, et al.
Published: (2023-01-01) -
Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
by: Jia-Kang Wang, et al.
Published: (2021-01-01) -
Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes
by: Hüseyin Baran Özdemir, et al.
Published: (2019-12-01)